The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

GLP-1s are driving traditional drug spending in the U.S. to unprecedented levels, which now outpaces specialty drug spending ...

are taking GLP-1 — glucagon-like peptide-1 — receptor agonists, medications that were initially developed and FDA-approved to treat Type 2 diabetes are also being used off-label for weight ...